TrialThe Journal of allergy and clinical immunology2019

Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms.

Raffaela Campana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.